Screening for prostate cancer using a blood test likely reduces the risk of dying from prostate cancer and may also reduce the risk of dying from any cause. Screening likely makes little to no ...
Morning Overview on MSN
A landmark review just reversed decades of recommendations on a blood test that detects a biomarker for one of the most common cancers
For more than a decade, millions of men heard the same message from their doctors: a routine PSA blood test probably was not ...
The Cochrane Library recently completed a review of “the comparative benefits, harms and tolerability of different smoking cessation pharmacotherapies and e-cigarettes, when used to help people stop ...
Decades of Alzheimer’s research has been dominated by one idea: Amyloid‑beta is the cause, and clearing it is the cure. Now, the world’s most trusted evidence authority has delivered a verdict that ...
There remains no evidence to support the use of ivermectin for treating or preventing COVID-19 infection, state the authors of an updated Cochrane Review, which now contains 11 trials across 3409 ...
A new Cochrane review casts doubt on the value of ketamine and other N-methyl-D-aspartate (NMDA) receptor agonists to relieve chronic noncancer pain. “Clinicians should know that there is currently no ...
Higher-potency topical corticosteroids, JAK inhibitors, and tacrolimus 0.1% were deemed the most effective topical anti-inflammatory treatments for atopic dermatitis (AD) following a network ...
Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results